Literature DB >> 945156

The diurnal rhythm of plasma aldosterone, plasma renin activity, plasma cortisol and serum growth hormone and subnormal responsiveness of aldosterone to angiotensin-II in the patients with normotensive acromegaly.

S Ichikawa, T Sakamaki, S Tonooka, Y Sugai.   

Abstract

The diurnal rhythm of plasma aldosterone concentration (PA), plasma renin activity (PRA), plasma cortisol (PC) and serum growth hormone (GH) were examined in 5 cases of normotensive acromegaly and the results were compared with the observations in normal subjects. Moreover, the response of PA to angiotensin-II infusion was studied in 6 cases of normotensive acromegaly. A normal diurnal rhythm with the lowest values in the evening or midnight and the highest values in the morning was observed in 3 of 5 cases in PA and 3 of 4 cases in PC. On the other hand, no apparent rhythm of GH was observed in any cases and that of PRA in 4 of 5 cases. Although there was a significant positive correlation between PA and PC, no significant correlation was demonstrated between PA and PRA. The response of PA to angiotensin-II fusion was significantly suppressed in normotensive acromegaly as compared to the normal subjects in spite of normal levels of PRA except for 1 case. The above observations were interpreted to suggest that the aldosterone regulation system is slightly altered in a certain number of patients with normotensive acromegaly in contrast to the normal subjects in which PRA is the main contributing factor. The low PA and suppressed response of PA toangiotensin-II infusion may suggest the defective action of angiotensin-II infusion on the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945156     DOI: 10.1507/endocrj1954.23.75

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  1 in total

1.  Circadian as well as circannual rhythms of circulating aldosterone have decreased amplitude in aging women.

Authors:  P Cugini; D Scavo; M Centanni; F Halberg; E Haus; D Lakatua; A Schramm; H J Pusch; H Franke; T Kawasaky
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.